From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Klaus Kümmerer

doi:10.1016/j.scp.2019.100136

From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Klaus Kümmerer

Professorship of Sustainable Chemistry and Material Resources

Research output: Journal contributions › Scientific review articles › Research

41 Citations (Scopus)

Abstract

Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

Original language	English
Article number	100136
Journal	Sustainable Chemistry and Pharmacy
Volume	12
Number of pages	4
ISSN	2352-5541
DOIs	https://doi.org/10.1016/j.scp.2019.100136
Publication status	Published - 06.2019

Bibliographical note

The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the ß-blockers.

Research areas and keywords

Sustainability Science
Chemistry
Pharmaceutical
Enviroment
Water
Soil
Chemoinformatic
Sustainable development goal
targeted design

ASJC Scopus Subject Areas

Pharmaceutical Science
Pollution
Environmental Chemistry
Management, Monitoring, Policy and Law

Access to Document

10.1016/j.scp.2019.100136

DBU Antibiotikum: Entwicklung eines umweltverträglichen Antibiotikums
Kümmerer, K. (Project manager, academic), Leder, C. (Project staff) & Rastogi, T. (Project staff)
German Federal Environmental Foundation
01.11.14 → 30.04.18
Project: Research

File
NANOPHARM: Neue photokatalytisch aktive Verbundmaterialien zur Eliminierung von pharmazeutischen Reststoffen
Kümmerer, K. (Project manager, academic) & Schneider, M. (Project staff)
Federal Ministry of Education and Research
01.10.10 → 30.09.13
Project: Research

Cite this

@article{863aac6cfc3040c28483ff6684dc6f41,

title = "From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability",

abstract = "Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.",

keywords = "Sustainability Science, Chemistry, Pharmaceutical, Enviroment, Water, Soil, Chemoinformatic, Sustainable development goal, targeted design",

author = "Klaus K{\"u}mmerer",

note = "The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the {\ss}-blockers.",

year = "2019",

month = jun,

doi = "10.1016/j.scp.2019.100136",

language = "English",

volume = "12",

journal = "Sustainable Chemistry and Pharmacy",

issn = "2352-5541",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

AU - Kümmerer, Klaus

N1 - The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the ß-blockers.

PY - 2019/6

Y1 - 2019/6

N2 - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

AB - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

KW - Sustainability Science

KW - Chemistry

KW - Pharmaceutical

KW - Enviroment

KW - Water

KW - Soil

KW - Chemoinformatic

KW - Sustainable development goal

KW - targeted design

UR - https://www.scopus.com/pages/publications/85062805316

U2 - 10.1016/j.scp.2019.100136

DO - 10.1016/j.scp.2019.100136

M3 - Scientific review articles

SN - 2352-5541

VL - 12

JO - Sustainable Chemistry and Pharmacy

JF - Sustainable Chemistry and Pharmacy

M1 - 100136

ER -

From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Abstract

Bibliographical note

Research areas and keywords

ASJC Scopus Subject Areas

Access to Document

Fingerprint

Projects

DBU Antibiotikum: Entwicklung eines umweltverträglichen Antibiotikums

NANOPHARM: Neue photokatalytisch aktive Verbundmaterialien zur Eliminierung von pharmazeutischen Reststoffen

Cite this